Indian Journal of PsychiatryIndian Journal of Psychiatry
Home | About us | Current Issue | Archives | Ahead of Print | Submission | Instructions | Subscribe | Advertise | Contact | Login 
    Users online: 448 Small font sizeDefault font sizeIncrease font size Print this article Email this article Bookmark this page
Search Again
 Back
 Table of Contents
 
 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Article Access Statistics
 Reader Comments
 Email Alert
 Add to My List
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed379    
    Printed29    
    Emailed0    
    PDF Downloaded35    
    Comments [Add]    

Recommend this journal

 
ARTICLE
Year : 1997  |  Volume : 39  |  Issue : 1  |  Page : 70-75

An Open Clinical Trial with Clozapine in Treatment-Resistant Schizophrenics


1 Professor & Head, KG. 's Medical College, Lucknow, India
2 Assistant Professor, KG. 's Medical College, Lucknow, India
3 Junior Resident, Department of Psychiatry, KG. 's Medical College, Lucknow, India
4 Associate Professor, Haematology, Upgraded Department of Pathology and Bacteriology, KG. 's Medical College, Lucknow, India

Correspondence Address:
Mukul Sharma
Assistant Professor, KG. 's Medical College, Lucknow
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


PMID: 21584048

Rights and PermissionsRights and Permissions

In an open trial, drug-resistant schizophrenics were treated with clozapine for sixteen weeks. The patients were rated on BPRS, PANSS, Side effects scale and Global Impression Scale at weeks 0. 9 and 16. I batten of base-tine investigations were (tone, and hemogram was repeated at weekly intervals. Of the total 29 patient included. 25 completed the trial. The patients showed significant improvement on both BPRS and PANSS, although the improvement was more in initial weeks than between 9 and 16 weeks. The most common side effects observed were sedation, hypersalivation and tachycardia. Issues of response of clozapine on negative symptoms and a longer duration of the drug therapy are discussed.



[PDF]*

        

Print this article         Email this article